Telemedicine in Functional Motor Disorder
Launched by UNIVERSITA DI VERONA · Apr 19, 2022
Trial Information
Current as of May 08, 2025
Unknown status
Keywords
ClinConnect Summary
Functional movement disorders (FMDs) are part of a broad spectrum of functional neurological disorders characterized by abnormal movements (gait, dystonia, and tremor), which are clinically incongruent with movement disorders caused by neurological disease and are significantly altered distraction or nonphysiologically maneuvers. FMDs have an incidence ranging from 4 to 12 per 100.000 population per year and a high prevalence (15-20%) in patients accessing neurological clinics. They are high disabling conditions characterized by long-term disability, poor quality of life, and economic impac...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • a clinically definite diagnosis of FMDs based on Gupta and Lang diagnostic criteria with the presence of distractibility maneuvers and a demonstration of positive signs;
- • the presence of 1 (isolated FMDs) or more clinical motor symptoms (combined FMDs), including weakness, tremor, jerks, dystonia, gait disorders, and parkinsonism;
- • acceptable level of digital skills.
- Exclusion Criteria:
- • prominent dissociative seizures
- • prominent cognitive and physical impairment that precludes signing the informed consent for participation in the study;
- • unable or refuse to attend the consecutive 5-day rehabilitation treatment
About Universita Di Verona
The Università di Verona is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university collaborates with various healthcare professionals and institutions to explore new therapies and improve patient outcomes. Its research initiatives are driven by a multidisciplinary approach, leveraging cutting-edge technology and methodologies. The Università di Verona aims to contribute significantly to the scientific community and public health by fostering rigorous clinical studies that address pressing medical challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Verona, , Italy
Patients applied
Trial Officials
Federico Schena, PhD
Study Director
Universita di Verona
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials